Skip to content

Effect of vitamin D supplement on quality of life and some blood biochemical factors in women with breast pain

Vitamin D supplement on quality of life, lipid profile and C - reactive protein among women with cyclical mastalgia

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017090210327N17
Enrollment
80
Registered
2017-10-16
Start date
2017-10-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D deficiency. Avitaminosis D

Interventions

Intervention 1: Intervention group: This group will receive 2000 IU of oral vitamin D per day for 8 weeks. Intervention 2: Control group: The control group will receive placebo for 8 weeks.
Placebo
Control group: The control group will receive placebo for 8 weeks.

Sponsors

Vice chancellor for research of Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: At least 18 years of age; serum level of vitamin D 10- 30 ng/ ml; breast pain duration of =5 days per menstrual cycle; without any somatic or psychological disease. Exclusion criteria : Pregnant or lactating women; history of breast cancer; Stressful life events such as death of a family member.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in quality of life. Timepoint: Before and after intervention. Method of measurement: Quality of life questionnaire.;Change in lipid profile. Timepoint: Before and after intervention. Method of measurement: Lab test.;Change in C- Reactive protein. Timepoint: Before and after intervention. Method of measurement: Lab test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarideh Vaziri

Shiraz University of Medical Sciences

roose82003@yahoo.com; vazirif@sums.ac.ir+98 71136281497

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026